Elif Ilkay Yuce

@elif_ilkay9

Interventional cardiologist

Dr. Ersin Arslan Training and Research Hospital - Gaziantep, Türkiye

Latest contributions

Ticagrelor monotherapy in patients at high bleeding risk undergoing percutaneous coronary intervention: TWILIGHT-HBR

28 Oct 2021

To further investigate the treatment effects of ticagrelor monotherapy compared with ticagrelor plus aspirin in a contemporary HBR population, a pre-specified analysis of the TWILIGHT trial, TWILIGHT-HBR, was conducted by using the Academic Research Consortium (ARC) criteria for HBR.

Reviewer

Ali Nazmi Calik

Reviewer

Elif Ilkay Yuce